Home
About Us
Post-Listing Company Specialising in great investor relations – this sample website shows how a newly listed company can look great for current and potential investors at all stages.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis rutrum sapien non ornare sagittis. Fusce quis dignissim felis. Pellentesque iaculis nisl et est ultricies, id mollis lorem volutpat.
Get all the latest corporate media releases via email
| Date | File Name |
|---|---|
| 23 March 2018 | Nature.com scientific report – Stevenson et al on Cantrixil |
| 06 December 2016 | Novogen Enrols First Patient into Phase I Study of Cantrixil |
| 11 August 2016 | Novogen submits IND Application to the FDA for Cantrixil |
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis rutrum sapien non ornare sagittis. Fusce quis dignissim felis. Pellentesque iaculis nisl et est ultricies, id mollis lorem volutpat.
Pellentesque iaculis nisl et est ultricies, id mollis lorem volutpat.
